Law360 (May 3, 2018, 12:56 PM EDT) -- Following this week’s oral argument at the U.S. Court of Appeals for the Federal Circuit, there has been a surge of interest in the long-running CRISPR patent dispute between the Regents of the University of California (with collaborators the University of Vienna and Emmanuelle Charpentier) and the Broad Institute (with collaborators Harvard and MIT). This article summarizes the broader patent war between those two sides and addresses its potential implications for others seeking to use CRISPR-based technologies.
The CRISPR spotlight in the U.S. is currently fixed on the Federal Circuit as it decides whether the Patent Trial and...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!